These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36323400)

  • 1. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
    Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
    Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.
    Rotz SJ; Hamilton BK; Wei W; Ahmed I; Winston SA; Ballard S; Bernard RJ; Carpenter P; Farhadfar N; Ferraro C; Friend BD; Gloude NJ; Hayashi RJ; Hoyle K; Jenssen K; Koo J; Lee CJ; Mariano L; Nawabit R; Ngwube A; Lalefar N; Phelan R; Perkins L; Rao A; Rayes A; Sandheinrich T; Stafford L; Tomlinson K; Whiteside S; Wiedl C; Myers K
    Transplant Cell Ther; 2024 May; 30(5):534.e1-534.e13. PubMed ID: 38342136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
    Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
    Transplant Cell Ther; 2023 Aug; 29(8):531.e1-531.e4. PubMed ID: 37169288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
    Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
    Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.
    Kawano M; Komura H; Kawaguchi H; Shimizu S; Yada-Hashimoto N; Shimizu M; Sato M; Inoue M; Ida S; Etani Y; Shoji Y; Nakacho M; Sawada K; Kimura T; Mitsuda N; Kurachi H
    Gynecol Endocrinol; 2017 Feb; 33(2):156-159. PubMed ID: 27808585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.
    Komori K; Hirabayashi K; Morita D; Hara Y; Kurata T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Koike K; Nakazawa Y
    Pediatr Transplant; 2019 May; 23(3):e13372. PubMed ID: 30714283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.
    Nakano H; Ashizawa M; Akahoshi Y; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
    Int J Hematol; 2016 Jul; 104(1):110-6. PubMed ID: 27084256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.
    Çiftçiler R; Göker H; Demiroğlu H; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe O; Tekin F; Büyükaşık Y
    Turk J Haematol; 2019 May; 36(2):88-96. PubMed ID: 30717586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders.
    Zhao J; Beebe K; Magee K; Salzberg D; Stahlecker J; Miller HK; Adams RH; Lipskind S; Walsh A; Mirea L; Ngwube A
    Pediatr Transplant; 2019 Sep; 23(6):e13496. PubMed ID: 31124253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male Gonadal Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Cross-Sectional, Population-Based Study.
    Mathiesen S; Sørensen K; Nielsen MM; Suominen A; Ifversen M; Grell K; Lähteenmäki P; Frederiksen H; Juul A; Müller K; Jahnukainen K
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1635-1645. PubMed ID: 32447044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
    Elchuri SV; Williamson Lewis R; Quarmyne MO; Haight AE; Cottrell HN; Meacham LR
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e575-e582. PubMed ID: 32205784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Anti-Mullerian Hormone Levels Pre- and Post-Hematopoietic Cell Transplantation in Pediatric and Adolescent Females with Sickle Cell Disease.
    George SA; Lai KW; Lewis RW; Bryson EW; Haight AE; Meacham LR
    Transplant Cell Ther; 2022 Nov; 28(11):770.e1-770.e6. PubMed ID: 35995392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
    Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Ovarian Function Assessment After Haematopoietic Stem Cell Transplantation in Female Sickle Cell Anaemia Survivors.
    Olowoselu O; Okunade KS; Oyedeji OA; Davies NO; Ajie OI; Adewoyin A; Kharya G
    Cureus; 2024 Apr; 16(4):e58195. PubMed ID: 38741860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.
    George SA; Veludhandi A; Xiang Y; Liu K; Stenger E; Arnold SD; Mehta A; Schirmer DA; Spencer JB; Guilcher GMT; Bhatia M; Abraham A; Gomez-Lobo V; Krishnamurti L; Meacham LR
    Transplant Cell Ther; 2024 Sep; 30(9):912.e1-912.e13. PubMed ID: 38972510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal development and function after immature testicular tissue banking as part of high-risk gonadotoxic treatment.
    Braye A; Delgouffe E; van der Werff Ten Bosch J; Gies I; Ferster A; Goossens E
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30370. PubMed ID: 37150973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].
    Xu QW; Du YY; Lyu KK; Xu MM; Gu CY; Kang HZ; Feng SL; Liu YJ; Wu DP; Han Y
    Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1303-1310. PubMed ID: 37935496
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.
    Ringdén O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hägglund H; Omazic B; Svenberg P; Dahllöf G; Mattsson J; Ljungman P; Remberger M
    J Intern Med; 2013 Aug; 274(2):153-62. PubMed ID: 23432209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.